Shenzhen Chipscreen Biosciences Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 533.46 million compared to CNY 430.45 million a year ago. Net income was CNY 17.33 million compared to CNY 21.96 million a year ago.

Basic earnings per share from continuing operations was CNY 0.043 compared to CNY 0.054 a year ago.